Myrbetriq ER 25 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FR07D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,251
Award facts
- Contract value 100% obligated
- $48,250.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $48.3K to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 25 mg tablets (30-count units) on January 6, 2026, with completion targeted for January 7, 2026. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $1B vehicle extending through December 2031 that provides comprehensive pharmaceutical and medical supply support for military healthcare systems globally.
Cencora, Inc., operating under the AmerisourceBergen brand, is a leading pharmaceutical distributor serving federal medical procurement needs across multiple therapeutic domains. This delivery order supports the Defense Health Agency and other military healthcare programs by supplying Myrbetriq, a medication used in the treatment of overactive bladder. The non-set-aside status of this award reflects full and open competition, demonstrating Cencora's established capability to meet federal pharmaceutical procurement requirements through its existing indefinite delivery vehicle.
Quick answers
Who was awarded contract SPE2DR26FR07D?
SPE2DR26FR07D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FR07D worth?
The government has obligated $48,251 on SPE2DR26FR07D.
Is contract SPE2DR26FR07D an order under another contract?
Yes. SPE2DR26FR07D is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR07D competed?
The extent of competition for SPE2DR26FR07D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award